Clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients with underlying autoimmune disease (AID).

Gulrayz Ahmed,Kaitlin Annunzio,Aniko Szabo,Daniel Eastwood,Bicky Thapa,Bradley Taylor,Susan Tsai,Kathleen K. Christians,Callisia N. Clarke,Douglas B. Evans,William A. Hall,Beth Erickson,Mandana Kamgar,Ben George

Clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients with underlying autoimmune disease (AID).

2021

Gulrayz Ahmed
Kaitlin Annunzio
Aniko Szabo
Daniel Eastwood
Bicky Thapa
Bradley Taylor
Susan Tsai
Kathleen K. Christians
Callisia N. Clarke
Douglas B. Evans
William A. Hall
Beth Erickson
Mandana Kamgar
Ben George

e16233Background: Chronic inflammation from AID and the resultant immunosuppression from treatment increases the risk of various malignancies. Risk of PDAC is increased in patients (pts) with AID, ...

Keywords:

Internal medicine
Medicine
in patient
Oncology
Autoimmune disease
Inflammation
Immunosuppression
pancreatic ductal adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations